Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shortening the Path to Rare Disease Diagnosis by Using Newborn Genetic Screening and Digital Technologies (SCREEN4CARE): Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project

NCT06549218 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT06549218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shortening the Path to Rare Disease Diagnosis by Using Newborn Genetic Screening and Digital Technologies (SCREEN4CARE): Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project
Lead sponsor
University Hospital Freiburg
Phase
Not applicable
Overall status
Recruiting
Start date
December 3, 2024
Completion date
December 31, 2026
Enrollment
20,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

newborn screening